Abstract
Influenza is a viral respiratory disease of great importance. Both seasonal and pandemic influenza pose serious burdens and threats to global public health. The current WHO strategy for influenza is based on the International Health Regulations revised in 2005 (IHR 2005), ensuring a core national public health capacity building alongside a systemic international response mechanism. Lessons and challenges from past threats such as highly pathogenic avian influenza outbreaks led to strengthening and reforms of the WHO strategy, including the expansion of the Global Influenza Surveillance and Response System, multi-sectoral collaboration with the One Health approach, adoption of the Pandemic Influenza Preparedness Framework, and the introduction of Emergency Risk Management for Health. In 2019, the WHO issued the Global Influenza Strategy to provide a framework aimed at strengthening the prevention and control of seasonal influenza and preparedness for future pandemics. Humankind managed to cope with the past global public health threats with WHO as the leader. However, the WHO faces mounting obstacles to fulfilling its purpose.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 “Spanish” influenza pandemic. Bull Hist Med. 2002;76(1):105–15. https://doi.org/10.1353/bhm.2002.0022.
Spreeuwenberg P, Kroneman M, Paget J. Reassessing the global mortality burden of the 1918 influenza pandemic. Am J Epidemiol. 2018;187(12):2561–7. https://doi.org/10.1093/aje/kwy191.
Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, et al. Influenza. Nat Rev Dis Primers. 2018;4(1):3. https://doi.org/10.1038/s41572-018-0002-y.
World Health Organization. Implementation of the International Health Regulations (2005); 2011.
Fan VY, Jamison DT, Summers LH. Pandemic risk: how large are the expected losses? Bull World Health Organ. 2018;96(2):129–34. https://doi.org/10.2471/BLT.17.199588.
World Health Organization. Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO, 2003-2020. 10 July 2020. https://www.who.int/influenza/human_animal_interface/2020_10_07_tableH5N1.pdf?ua=1. Accessed 9 Aug 2020.
Widdowson MA, Bresee JS, Jernigan DB. The global threat of animal influenza viruses of zoonotic concern: then and now. J Infect Dis. 2017;216(Suppl. 4):S493–8. https://doi.org/10.1093/infdis/jix331.
Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature. 2012;486(7403):420–8. https://doi.org/10.1038/nature10831.
Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science. 2012;336(6088):1534–41. https://doi.org/10.1126/science.1213362.
World Health Organization. Global influenza strategy 2019–2030. Geneva: World Health Organization; 2019. https://apps.who.int/iris/bitstream/handle/10665/311184/9789241515320-eng.pdf?sequence=18&isAllowed=y. Accessed 9 Aug 2020.
Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet (London, England). 2018;391(10127):1285–300. https://doi.org/10.1016/S0140-6736(17)33293-2.
Troeger CE, Blacker BF, Khalil IA, Zimsen SRM, Albertson SB, Abate D, et al. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2019;7(1):69–89. https://doi.org/10.1016/S2213-2600(18)30496-X.
Wang X, Li Y, O’Brien KL, Madhi SA, Widdowson M-A, Byass P, et al. Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study. Lancet Glob Health. 2020;8(4):e497–510. https://doi.org/10.1016/s2214-109x(19)30545-5.
Peasah SK, Azziz-Baumgartner E, Breese J, Meltzer MI, Widdowson MA. Influenza cost and cost-effectiveness studies globally--a review. Vaccine. 2013;31(46):5339–48. https://doi.org/10.1016/j.vaccine.2013.09.013.
de Francisco Shapovalova N, Donadel M, Jit M, Hutubessy R. A systematic review of the social and economic burden of influenza in low- and middle-income countries. Vaccine. 2015;33(48):6537–44. https://doi.org/10.1016/j.vaccine.2015.10.066.
World Health Organization. National Influenza Centres. 28 July 2020. https://www.who.int/influenza/gisrs_laboratory/national_influenza_centres/National_Influenza_Centres_20200728_web.pdf?ua=1. Accessed 9 Aug 2020.
World Health Organization. WHO preferred product characteristics for next-generation influenza vaccines; 2017.
Yamayoshi S, Kawaoka Y. Current and future influenza vaccines. Nat Med. 2019;25(2):212–20. https://doi.org/10.1038/s41591-018-0340-z.
World Health Organization. WHO guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other Influenza Viruses Part1. 2010. https://www.who.int/csr/resources/publications/swineflu/h1n1_guidelines_pharmaceutical_mngt.pdf?ua=1. Accessed 9 Aug 2020.
FAO-OIE-WHO. The FAO-OIE-WHO Collaboration: a Tripartite Concept Note Sharing responsibilities and coordinating global activities to address health risks at the animal-human-ecosystems interfaces. 2010. https://www.who.int/influenza/resources/documents/tripartite_concept_note_hanoi_042011_en.pdf?ua=1. Accessed 9 Aug 2020.
World Health Organization. Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits. 2011. https://apps.who.int/iris/bitstream/handle/10665/44796/9789241503082_eng.pdf?sequence=1. Accessed 9 Aug 2020.
World Health Organization. Pandemic influenza risk management WHO Interim Guidance. 2013. https://www.who.int/influenza/preparedness/pandemic/GIP_PandemicInfluenzaRiskManagementInterimGuidance_Jun2013.pdf?ua=1. Accessed 9 Aug 2020.
World Health Organization. International Health Regulations (1969). 1983. https://apps.who.int/iris/bitstream/handle/10665/96616/9241580070.pdf?sequence=1. Accessed 9 Aug 2020.
Morse SS, Mazet JAK, Woolhouse M, Parrish CR, Carroll D, Karesh WB, et al. Prediction and prevention of the next pandemic zoonosis. Lancet. 2012;380(9857):1956–65. https://doi.org/10.1016/s0140-6736(12)61684-5.
World Health Organization. International Health Regulations 2005. 3rd ed; 2016.
Fineberg HV. Pandemic preparedness and response—lessons from the H1N1 influenza of 2009. N Engl J Med. 2014;370(14):1335–42. https://doi.org/10.1056/NEJMra1208802.
Fidler DP. Negotiating equitable access to influenza vaccines: global health diplomacy and the controversies surrounding avian influenza H5N1 and pandemic influenza H1N1. PLoS Med. 2010;7(5):e1000247. https://doi.org/10.1371/journal.pmed.1000247.
World Health Organization. Report of the WHO pandemic influenza A(H1N1) vaccine deployment initiative; 2012.
World Health Organization. Urgent support for developing countries’ responses to the H1N1 influenza pandemic. 2009. https://reliefweb.int/sites/reliefweb.int/files/resources/47A26C749293325185257663005F6EE9-Full_Report.pdf. Accessed 9 Aug 2020.
World Health Organization. Main operational lessons learnt from the WHO Pandemic Influenza A(H1N1) Vaccine Deployment Initiative. 2011. https://apps.who.int/iris/bitstream/handle/10665/44711/9789241564342_eng.pdf?sequence=1&isAllowed=y. Accessed 9 Aug 2020.
Gostin LO, Phelan A, Stoto MA, Kraemer JD, Reddy KS. Virus sharing, genetic sequencing, and global health security. Science (New York, NY). 2014;345(6202):1295–6. https://doi.org/10.1126/science.1257622.
Gostin LO, DeBartolo MC, Katz R. The global health law trilogy: towards a safer, healthier, and fairer world. Lancet. 2017;390(10105):1918–26. https://doi.org/10.1016/s0140-6736(17)31261-8.
World Health Organization. Report of the 2016 PIP Framework Review Group. 2017. https://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_17-en.pdf?ua=1. Accessed 13 Aug 2020.
Shu Y, McCauley J. GISAID: global initiative on sharing all influenza data - from vision to reality. Euro Surveill. 2017;22:13. https://doi.org/10.2807/1560-7917.ES.2017.22.13.30494.
World Health Organization. Implementation of the Nagoya protocol and pathogen sharing: public health implications. https://www.who.int/docs/default-source/documents/nagoya-protocol/nagoya-full-study-english.pdf?sfvrsn=ec2ab49d_12. Accessed 9 Aug 2020.
World Health Organization. Pandemic influenza risk management: a WHO guide to inform and harmonize national and international pandemic preparedness and response. 2017. https://apps.who.int/iris/bitstream/handle/10665/259893/WHO-WHE-IHM-GIP-2017.1-eng.pdf?sequence=1&isAllowed=y. Accessed 9 Aug 2020.
World Health Organization. Joint external evaluation tool second edition. 2018. https://extranet.who.int/sph/sites/default/files/document-library/document/9789241550222-eng.pdf. Accessed 9 Aug 2020.
Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature. 2008;451(7181):990–3. https://doi.org/10.1038/nature06536.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Imamura, T., Oshitani, H. (2021). Global Strategy for Influenza Viral Infection: What Is the Latest Information from WHO?. In: Fujita, J. (eds) Influenza. Respiratory Disease Series: Diagnostic Tools and Disease Managements. Springer, Singapore. https://doi.org/10.1007/978-981-15-9109-9_1
Download citation
DOI: https://doi.org/10.1007/978-981-15-9109-9_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-9108-2
Online ISBN: 978-981-15-9109-9
eBook Packages: MedicineMedicine (R0)